
FDA Gives Rare Cancer Treatment Fast Track Designation
Italfarmaco S.p.A. announced that the FDA has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV), a rare hematologic cancer, for which treatment options are limited. “The FDA decision to grant givinostat …